Bismuth Subsalicylate
- PMID: 32809532
- Bookshelf ID: NBK560697
Bismuth Subsalicylate
Excerpt
This educational activity focuses on bismuth subsalicylate's applications in managing gastrointestinal discomfort and traveler's diarrhea. The drug's mechanism of action, potential adverse reactions, and contraindications will be discussed. By also exploring bismuth subsalicylate's pharmacokinetics, optimal administration methods, and necessary monitoring protocols, this program aims to enhance professionals' proficiency in clinical toxicology related to the medication. The goal of this program is to furnish healthcare professionals with the requisite expertise to administer bismuth subsalicylate optimally. By providing evidence-based information, this discussion facilitates informed decision-making, enabling practitioners to tailor treatment strategies to individual patient needs. By understanding bismuth subsalicylate's intricacies, healthcare professionals can mitigate adverse reactions, optimize dosages, and deliver precise, safe, and individualized care.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Koulinska I, Riester K, Chalkias S, Edwards MR. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study. Clin Ther. 2018 Dec;40(12):2021-2030.e1. - PubMed
-
- Hailey FJ, Newsom JH. Evaluation of bismuth subsalicylate in relieving symptoms of indigestion. Arch Intern Med. 1984 Feb;144(2):269-72. - PubMed
Publication types
LinkOut - more resources
Full Text Sources